SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?


To: Michael Kucera who wrote (2071)5/25/1999 4:02:00 AM
From: Dan Spillane  Respond to of 2539
 
Any comments for: Committee on Genetically Modified Pest Protected Plants?

Project Scope:
The committee will investigate risks and benefits of genetically modified pest protected (GMPP) plants, and the Coordinated Framework for Regulation of Biotechnology (Coordinated Framework) affecting the use of these plants. The study will 1) review the principles in the NAS Council's white paper, "Introduction of rDNA-Engineered Organisms into the Environment"(1987), for their continued scientific validity and assess their appropriateness for current decisions regarding GMPP plants, 2) review scientific data which address the risks and benefits of GMPP plants, 3) examine the existing and proposed regulations in light of the identified risks and benefits, 4) examine existing and proposed regulations to qualitatively assess their consequences for research, development, and commercialization of GMPP plants, and 5) provide recommendations to address the identified risks/benefits, and, if warranted, for the existing and proposed regulation of GMPP plants.

NOTE: The purpose of this study is to assess the scientific basis for regulating the approval and use of GMPP plants. The study will not address philosophical and social issues surrounding the use of genetic engineering in agriculture, food labeling, or international trade in genetically modified plants.

(see the instructions at the bottom of this page to submit comments)
www4.nas.edu



To: Michael Kucera who wrote (2071)5/25/1999 9:24:00 AM
From: Bomar  Respond to of 2539
 
Thanks for that.....I would agree that 207m is nothing but a portfolio management move by the guy. I certainly would do the same. In terms of price levels...the range has been 38-50 for the last few months so building a position at these levels looks good...I will be selling 40 puts today...

Thanks...Bomar